comparemela.com

Latest Breaking News On - Getty images moderna - Page 1 : comparemela.com

Moderna says booster likely needed before winter

Moderna says booster likely needed before winter
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

United statesStephane bancelWorld health organizationGetty images modernaWorld healthஒன்றுபட்டது மாநிலங்களில்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்கெட்டி படங்கள் மாடர்னாஉலகம் ஆரோக்கியம்

Moderna providing up to 500M vaccine doses to UN-backed program for lower-income countries

Moderna providing up to 500M vaccine doses to UN-backed program for lower-income countries Justine Coleman © Getty Images Moderna providing up to 500M vaccine doses to UN-backed program for lower-income countries Moderna on Monday committed to providing up to 500 million doses of its COVID-19 vaccine to a United Nations-backed program designed to supply vaccinations to middle- and low-income countries. The company announced an agreement with Gavi, the Vaccine Alliance, in which Moderna pledged to give a maximum of 500 million doses to the COVAX Facility, including an initial 34 million doses within the fourth quarter of this year. The deal also permits Gavi to obtain 466 million additional vaccine doses in 2022 at Moderna s lowest tiered price.

World health organizationVaccine allianceSerum institute of indiaCoalition for epidemic preparedness innovationsGetty images modernaUnited nations backedEpidemic preparedness innovationsSerum instituteஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்தடுப்பூசி கூட்டணிசீரம் நிறுவனம் ஆஃப் இந்தியாகூட்டணி க்கு பெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் புதுமைகள்கெட்டி படங்கள் மாடர்னாபெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் புதுமைகள்சீரம் நிறுவனம்

Healthcare CEOs on how the pandemic is shaping the future of work

Healthcare CEOs on how the pandemic is shaping the future of work adunn@businessinsider.com (Andrew Dunn) © Crystal Cox/Insider Pfizer CEO Albert Bourla. Crystal Cox/Insider Popular Searches These are the people steering healthcare s future, and we got them to share their thoughts on the future of work-from-home, the industry s diversity and equity challenges, and lessons learned from the past year. (You can also check out the answers of some non-healthcare CEOs at places like Dropbox, Ogilvy, and Hooters.) Bourla is hoping to usher in a new era at Pfizer, applying the R&D learnings from its coronavirus vaccine work to other diseases and medicines.

United statesNew yorkCarl zimmerPatricia kelly yeoAndrew dunnAlbert bourlaWalter isaacsonKaren desalvoApril joynerJen gunterAllison deangelisGail boudreauxAmy klobucharAmelia russellJennifer doudnaInsider book club

Moderna plans to produce up to 3 billion COVID-19 vaccine doses next year, citing a significant need for shots and boosters into 2023

Moderna plans to produce up to 3 billion COVID-19 vaccine doses next year, citing a significant need for shots and boosters into 2023 adunn@businessinsider.com (Andrew Dunn) © Mario Tama/Getty Images A nurse administers a dose of the Moderna vaccine in Los Angeles, California. Between 20 and 40% of frontline workers in Los Angeles have refused a shot. Mario Tama/Getty Images Moderna will make up to 3 billion doses of its COVID-19 vaccine in 2022, the biotech said Thursday. The CEO said there will continue to be significant need for shots and boosters in 2022 and 2023. The company is testing lower doses as booster shots, which could expand future supply.

Al iskandariyahUnited statesUnited kingdomLos angelesMario tama gettyStephane bancelAlbert bourlaSteven ferdman gettyUs centers for diseaseAlexandria real estate equitiesGetty imagesGetty images modernaDisease controlஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்லாஸ் ஏஞ்சல்ஸ்

Elizabeth Warren and other Democratic senators demand to know how US pharmaceutical companies plan to share vaccine technology as COVID-19 devastates India

Elizabeth Warren and other Democratic senators demand to know how US pharmaceutical companies plan to share vaccine technology as COVID-19 devastates India cdavis@insider.com (Charles Davis) © GUILLAUME SOUVANT/AFP via Getty Images Moderna chose the firm Recipharm to produce part of its vaccine against COVID-19 in France. GUILLAUME SOUVANT/AFP via Getty Images Senate Democrats are asking vaccine makers what their plans are to share intellectual property. The questions come as developing nations struggle to inoculate their populations against COVID-19. In the next few weeks, more than half of Americans will have received at least one dose of a coronavirus vaccine. In much of the developing world, if current trends hold, people will be lucky to get a shot by 2022 - all the more reason, a group of US senators say, that pharmaceutical companies should be sharing their know-how and hastening the end to this global health crisis.

South africaUnited statesJeff merkleyElizabeth warrenEdward markeyJoe bidenSuhaib siddiqiNarendra modiChristopher murphyTammy baldwinLisa cannellosSenate democratsEuropean unionAssociated pressWorld trade organizationGetty images moderna

vimarsana © 2020. All Rights Reserved.